Last week, the Biotech industry hasn't moved much but Telix Pharmaceuticals is up 4.7% in that time. Unfortunately though, the industry is down 9.2% over the past 12 months. As for the next few years, earnings are expected to grow by 16% per annum.
Has the Australian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 22 May 2024 | AU$144.1b | AU$22.0b | AU$3.2b | 30.9x | 44.8x | 6.5x |
Fri, 19 Apr 2024 | AU$140.0b | AU$22.9b | AU$3.4b | 29.7x | 41.7x | 6.1x |
Sun, 17 Mar 2024 | AU$143.3b | AU$22.4b | AU$3.3b | 30.5x | 43.7x | 6.4x |
Tue, 13 Feb 2024 | AU$147.7b | AU$21.0b | AU$2.9b | 33.7x | 51.6x | 7x |
Thu, 11 Jan 2024 | AU$148.3b | AU$20.5b | AU$2.7b | 34.9x | 54.8x | 7.2x |
Sat, 09 Dec 2023 | AU$135.8b | AU$20.8b | AU$2.8b | 33.8x | 49.3x | 6.5x |
Mon, 06 Nov 2023 | AU$124.1b | AU$21.1b | AU$2.8b | 30x | 44.2x | 5.9x |
Wed, 04 Oct 2023 | AU$126.5b | AU$21.6b | AU$2.8b | 29x | 44.6x | 5.9x |
Fri, 01 Sep 2023 | AU$140.0b | AU$21.3b | AU$2.6b | 34.9x | 54.3x | 6.6x |
Sun, 30 Jul 2023 | AU$137.8b | AU$18.1b | AU$2.3b | 37.4x | 59x | 7.6x |
Tue, 27 Jun 2023 | AU$143.9b | AU$18.0b | AU$2.3b | 37.4x | 61.8x | 8x |
Thu, 25 May 2023 | AU$156.4b | AU$18.3b | AU$2.4b | 41x | 66x | 8.5x |
Sat, 22 Apr 2023 | AU$154.4b | AU$18.0b | AU$2.3b | 41.8x | 66.7x | 8.6x |
Mon, 20 Mar 2023 | AU$146.6b | AU$17.9b | AU$2.3b | 40.9x | 63.3x | 8.2x |
Wed, 15 Feb 2023 | AU$156.4b | AU$17.1b | AU$2.3b | 52.3x | 69.5x | 9.1x |
Fri, 13 Jan 2023 | AU$143.9b | AU$15.6b | AU$2.5b | 49.5x | 58.2x | 9.2x |
Sun, 11 Dec 2022 | AU$152.4b | AU$15.8b | AU$2.5b | 47.9x | 60.6x | 9.6x |
Tue, 08 Nov 2022 | AU$142.0b | AU$16.7b | AU$2.7b | 42.6x | 53.2x | 8.5x |
Thu, 06 Oct 2022 | AU$147.9b | AU$16.5b | AU$2.7b | 43.4x | 55.8x | 8.9x |
Sat, 03 Sep 2022 | AU$150.5b | AU$15.9b | AU$2.5b | 44.2x | 59.5x | 9.5x |
Mon, 01 Aug 2022 | AU$147.5b | AU$15.5b | AU$2.8b | 40.2x | 53x | 9.5x |
Wed, 29 Jun 2022 | AU$138.3b | AU$15.5b | AU$2.8b | 36x | 49.4x | 8.9x |
Fri, 27 May 2022 | AU$138.3b | AU$15.3b | AU$2.7b | 35.8x | 50.4x | 9.1x |
Sun, 24 Apr 2022 | AU$137.7b | AU$14.8b | AU$2.7b | 38x | 51.1x | 9.3x |
Tue, 22 Mar 2022 | AU$136.4b | AU$14.5b | AU$2.6b | 39.8x | 51.8x | 9.4x |
Thu, 17 Feb 2022 | AU$136.7b | AU$15.1b | AU$2.7b | 39x | 50.2x | 9.1x |
Sat, 15 Jan 2022 | AU$143.5b | AU$14.3b | AU$2.7b | 40.6x | 52.6x | 10x |
Mon, 13 Dec 2021 | AU$148.5b | AU$14.6b | AU$2.8b | 41x | 53.4x | 10.2x |
Wed, 10 Nov 2021 | AU$155.6b | AU$14.1b | AU$2.7b | 44.3x | 58.4x | 11x |
Fri, 08 Oct 2021 | AU$143.5b | AU$14.5b | AU$2.7b | 40x | 52.5x | 9.9x |
Sun, 05 Sep 2021 | AU$150.9b | AU$14.0b | AU$2.6b | 43.7x | 57.5x | 10.8x |
Tue, 03 Aug 2021 | AU$144.8b | AU$14.0b | AU$2.6b | 42.3x | 55.1x | 10.4x |
50.3x
Which industries have driven the changes within the Australian Healthcare industry?
AU Market | 1.47% | |
Healthcare | -1.42% | |
Biotech | -0.53% | |
Biotech | -0.53% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TLX Telix Pharmaceuticals | AU$15.78 | 4.7% +AU$292.6m | 37.2% | PE1011.8x | |
MSB Mesoblast | AU$1.15 | 9.5% +AU$114.1m | 9.0% | PS117.1x | |
IMM Immutep | AU$0.47 | 6.7% +AU$35.7m | 33.8% | PS143.7x | |
ATH Alterity Therapeutics | AU$0.006 | 20.0% +AU$5.2m | -14.3% | PS9.2x | |
ARX Aroa Biosurgery | AU$0.49 | 3.1% +AU$5.2m | -45.0% | PS2.7x |